Can a phone app beat standard care for MS fatigue?

NCT ID NCT06386133

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a digital tool called MSCopilot Boost can reduce the impact of fatigue in people with multiple sclerosis better than standard care. The tool includes remote monitoring of walking, dexterity, vision, and cognition, plus a personalized telerehabilitation program. 208 participants will be followed for 9 months to see if fatigue scores improve.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MSCopilot Boost (a digital tool with remote monitoring and telerehabilitation)

What this could lead to

If it works, this could provide a new way to manage chronic fatigue in multiple sclerosis using a smartphone app and personalized exercise program.

What could go wrong

This is a relatively small study (208 people) testing a digital intervention, not a drug. The results may not apply to all MS patients, and the benefit may be modest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis myalgic encephalomeyelitis/chronic fatigue syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••